Health tech specialists GoodCell are working with the New York Blood Center to identify COVID-19 patients with elevated risk of adverse clinical outcomes.
Mispro is expanding its vivarium service network with the opening of its fifth facility, an 18,000 square foot facility in Broad Hollow Bioscience Park, NY.
Pharma firms making product benefit claims on Twitter must incorporate risk information within the same tweet regardless of character space limitations, says the US FDA.
This month’s roundup features LabCorp newly created enterprise-wide chief medical officer position and two new hires at WIRB-Copernicus Group’s eCOA arm.
Former employees of Procter & Gamble, Merck & Co. and Bristol Myers Squibb have all found new homes in the pharma industry in this week's People column.
Teva and Bristol-Myers Squibb have announced new Board Members whilst Roche is preparing to lose one - welcom to in-Pharmatechnologist's People on the Move.
Bayer is to have a new Head of Healthcare and the UK MHRA is to have a new leadership team - welcome to in-Pharmatechnologist.com's People on the Move.
inVentiv Health’s medical communications business is opening two new offices in Tokyo and New York City to be closer to clients and integrate further with the company’s clinical teams.
Biopharma companies are looking for more pre-fabrication of their facilities and to be able to expedite construction and meet tighter timelines, an expert told Outsourcing-Pharma.com.
The ten biggest drugmakers in the world want faster, more efficient R&D and claim a new non-profit organisation they formed last week is the solution to the industries development bottlenecks.
Recognition of glass vial quality issues is supporting interest in West’s analytical capabilities and Crystal Zenith (CZ) products, new sizes of which are being developed, said a company VP.
Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.
US drug giant Pfizer hopes that its collaboration with student
engineers at New Jersey's Rowan University will help lessen the
environmental impact of its best selling arthritis drug Celebrex
(celeboxib).
Swedish construction firm Skanska today announced that it has been
awarded a multi-million dollar contract to expand a pharmaceutical
facility in the US, though the company is keeping the identity of
its client close to its chest.
Millipore are to showcase a range of filtration, chromatography,
process monitoring and water purification solutions that are a part
of Millipore's response to an increase in lab investments from
pharma companies, and the emergence...
Pliva has continued its rapid expansion with the opening of a new
R&D facility in the USA that will carry out formulation work on
generic pharmaceuticals.
